IFNA1 and Kaposi's sarcoma: It should be highlighted that currently, IFN-α is proposed for the treatment of HIV patients only when they are infected by hepatitis C virus or in cases of Kaposi's sarcoma and as a combined therapy of IFN-α with different antiretroviral drugs [9].